Uterine Carcinosarcoma — Trials

Uterine Carcinosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

34 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 8
Recruiting: 5
Ph III recruiting: 3
Growth YoY: —
Industry share: 13%
Top sponsor: ARCAGY/ GINECO GROUP
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01367301	Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer	terminated	N/A	14	Albert Einstein College of MedicineOTHER	1	Aug 21, 2023	clinicaltrials

Data updated 22 days agoSource updated Aug 21, 2023source: clinicaltrials